FDA Adverse Event Injury Summary report: N

HYLAFORM PLUS

MDR report key: 586252 · Received March 28, 2005

Report

Report Number
2246315-2005-00028
Event Type
Injury
Date Received
March 28, 2005
Date of Event
February 24, 2005
Report Date
February 28, 2005
Manufacturer
GENZYME BIOSURGERY
Product Code
LMH
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Description of Event or Problem · 1

REPORT RECEIVED FROM A PHYSICIAN IN FEB 2005 REGARDING A PT WITH A HISTORY SINCE 2001 OF BOVINE COLLAGEN INJECTIONS (WITH NO ADVERSE EFFECTS), NO KNOWN ALLERGIES AND NO HISTORY OF AUTOIMMUNE DISEASE, WHO RECEIVED INJECTIONS OF HYLAFORM PLUS IN FEB 2005 TO THE NASOLABIAL FOLDS, MARIONETTE LINES AND PERIORAL LINES. TWO WEEKS LATER, THE INJECTION PT EXPERIENCED SWELLING AT INJECTION SITES; REDNESS AT INJECTION SITES; INDURATION AT INJECTION SITES; PRURITUS AT INJECTION SITE FOUR DAYS LATER PHYSICIAN EXAMINED THE PT AND DIAGNOSED AN ALLERGIC REACTION; ORAL PREDNISONE AND TOPICAL PANDEL CREAM (DOSES AND ONSET DATES NOT PROVIDED) WERE PRESCRIBED. AT THE TIME OF THE REPORT, THE PT HAD NOT YET RECOVERED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 HYLAFORM PLUS DERMAL IMPLANT FOR AESTHETIC USE LMH GENZYME BIOSURGERY NA W0408

Patients

Seq Age Sex Outcome Treatment
1 66 YR Required Intervention